|
|
Blood, 1 April 2006, Vol. 107, No. 7, pp. 2830-2838.
Prepublished online as a Blood First Edition Paper on December 6, 2005; DOI 10.1182/blood-2005-06-2403.
Previous Article | Next Article 
Submitted June 16, 2005
Accepted November 21, 2005
Persistence of naive CD45RA+ regulatory T cells in adult life
Nabila Seddiki, Brigitte Santner-Nanan, Stuart G Tangye, Stephen I Alexander, Michael Solomon, Soon Lee, Ralph Nanan, and Barbara Fazekas de St Groth*
Centenary Institute of Cancer Medicine and Cell Biology, Newtown, NSW, Australia
Department of Pediatrics, University of Sydney, Western Clinical School, Penrith, NSW, Australia
The Childrens Hospital at Westmead, Westmead, NSW, Australia
The Royal Prince Alfred Hospital, Camperdown, NSW, Australia
* Corresponding author; email: b.fazekas{at}centenary.usyd.edu.au.
Regulatory T cells (Treg) constitutively expressing CD4, CD25 and the transcription factor Foxp3 can prevent a wide range of experimental and spontaneous autoimmune diseases in mice. In humans, CD4+CD25bright T cells, predominantly within the CD45RO+ activated/memory subset in adults and the CD45RA+ naive T cell subset in infants, are considered to be the equivalent subset. Using novel combinations of mAbs, we examined expression of CD25 in human infant thymus, cord blood, adult peripheral blood, lymph node and spleen. In addition to the CD4+CD25bright T cells, subfractionation on the basis of CD45 splice variants indicated that all samples contained a second distinct population of cells expressing a slightly lower level of CD25. In adult peripheral blood, this population expressed a naive CD45RA+ phenotype. The corresponding population in lymph node, spleen and cord blood showed some evidence of activation, and expressed markers characteristic of Treg, such as CTLA-4. Sorted CD4+CD25+CD45RA+ T cells from both cord and adult blood expressed very high levels of mRNA for Foxp3 and manifested equivalent suppressive activity in vitro, indicating that they are bone fide members of the regulatory T cell lineage. Targeting naive Treg in adults may offer new means of preventing and treating autoimmune disease.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Grindebacke, H. Stenstad, M. Quiding-Jarbrink, J. Waldenstrom, I. Adlerberth, A. E. Wold, and A. Rudin
Dynamic Development of Homing Receptor Expression and Memory Cell Differentiation of Infant CD4+CD25high Regulatory T Cells
J. Immunol.,
October 1, 2009;
183(7):
4360 - 4370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Zaunders, M. L. Munier, N. Seddiki, S. Pett, S. Ip, M. Bailey, Y. Xu, K. Brown, W. B. Dyer, M. Kim, et al.
High Levels of Human Antigen-Specific CD4+ T Cells in Peripheral Blood Revealed by Stimulated Coexpression of CD25 and CD134 (OX40)
J. Immunol.,
August 15, 2009;
183(4):
2827 - 2836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Wang, L. Kozhaya, F. Mercer, A. Khaitan, H. Fujii, and D. Unutmaz
Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells
PNAS,
August 11, 2009;
106(32):
13439 - 13444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. H. E. Mabarrack, N. L. Turner, and G. Mayrhofer
Recent thymic origin, differentiation, and turnover of regulatory T cells
J. Leukoc. Biol.,
November 1, 2008;
84(5):
1287 - 1297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. P. M. Koenen, R. L. Smeets, P. M. Vink, E. van Rijssen, A. M. H. Boots, and I. Joosten
Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells
Blood,
September 15, 2008;
112(6):
2340 - 2352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Venken, N. Hellings, T. Broekmans, K. Hensen, J.-L. Rummens, and P. Stinissen
Natural Naive CD4+CD25+CD127low Regulatory T Cell (Treg) Development and Function Are Disturbed in Multiple Sclerosis Patients: Recovery of Memory Treg Homeostasis during Disease Progression
J. Immunol.,
May 1, 2008;
180(9):
6411 - 6420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Santner-Nanan, N. Seddiki, E. Zhu, V. Quent, A. Kelleher, B. F. de St Groth, and R. Nanan
Accelerated age-dependent transition of human regulatory T cells to effector memory phenotype
Int. Immunol.,
March 1, 2008;
20(3):
375 - 383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Atanackovic, Y. Cao, T. Luetkens, J. Panse, C. Faltz, J. Arfsten, K. Bartels, C. Wolschke, T. Eiermann, A. R. Zander, et al.
CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation
Haematologica,
March 1, 2008;
93(3):
423 - 430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Antons, R. Wang, K. Oswald-Richter, M. Tseng, C. W. Arendt, S. A. Kalams, and D. Unutmaz
Naive Precursors of Human Regulatory T Cells Require FoxP3 for Suppression and Are Susceptible to HIV Infection
J. Immunol.,
January 15, 2008;
180(2):
764 - 773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Haas, B. Fritzsching, P. Trubswetter, M. Korporal, L. Milkova, B. Fritz, D. Vobis, P. H. Krammer, E. Suri-Payer, and B. Wildemann
Prevalence of Newly Generated Naive Regulatory T Cells (Treg) Is Critical for Treg Suppressive Function and Determines Treg Dysfunction in Multiple Sclerosis
J. Immunol.,
July 15, 2007;
179(2):
1322 - 1330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Beyer and J. L. Schultze
CD4+CD25highFOXP3+ Regulatory T Cells in Peripheral Blood Are Primarily of Effector Memory Phenotype
J. Clin. Oncol.,
June 20, 2007;
25(18):
2628 - 2630.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Hoffmann, R. Eder, T. J. Boeld, K. Doser, B. Piseshka, R. Andreesen, and M. Edinger
Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion
Blood,
December 15, 2006;
108(13):
4260 - 4267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Fritzsching, N. Oberle, E. Pauly, R. Geffers, J. Buer, J. Poschl, P. Krammer, O. Linderkamp, and E. Suri-Payer
Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death
Blood,
November 15, 2006;
108(10):
3371 - 3378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. W. Lim, H. E. Broxmeyer, and C. H. Kim
Regulation of Trafficking Receptor Expression in Human Forkhead Box P3+ Regulatory T Cells
J. Immunol.,
July 15, 2006;
177(2):
840 - 851.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Seddiki, B. Santner-Nanan, J. Martinson, J. Zaunders, S. Sasson, A. Landay, M. Solomon, W. Selby, S. I. Alexander, R. Nanan, et al.
Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells
J. Exp. Med.,
July 10, 2006;
203(7):
1693 - 1700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Beyer, M. Kochanek, T. Giese, E. Endl, M. R. Weihrauch, P. A. Knolle, S. Classen, and J. L. Schultze
In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma
Blood,
May 15, 2006;
107(10):
3940 - 3949.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|